HALO

Halozyme Therapeutics Inc

Price:

40.93

USD

Volume:

694,326.00

United States | Biotechnology

35.62 %

Upside

As of 2024-03-05, the Fair Value of Halozyme Therapeutics Inc (HALO) is 55.51 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 40.93 USD, the upside of Halozyme Therapeutics Inc is 35.62%.

40.93 USD

Stock Price

55.51 USD

Fair Price

Peter Lynch's formula is:

HALO Fair Value

= Earnings Growth Rate x TTM EPS
HALO Fair Value

= 25.00 x 2.22
HALO Fair Value

= 55.51
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | -72.20 | 129.10 | 402.70 | 202.10 | 281.59 | 188.66 |

YoY growth | 10.09% | 278.81% | 211.93% | -49.81% | 39.33% | 98.07% |

Market Cap (mil) | 5,190.74 |

P/E | 18.43x |

Forward P/E | 17.33x |

EPS | 2.22 |

Avg earnings growth rate | 98.07% |

TTM earnings | 281.59 |